PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
We Are Actively Engaged As Trabectedin Injection Supplier, Manufacturer And Exporter, Our Range of Pharma Products Are Tested By Experts To Assure Its Effectiveness On Various Parameters .
